Robert G. Kramer
2019
In 2019, Robert G. Kramer earned a total compensation of $3.7M as President and Chief Executive Officer at Emergent BioSolutions, a 54% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $557,108 |
|---|---|
| Option Awards | $1,012,999 |
| Salary | $678,021 |
| Stock Awards | $1,439,958 |
| Other | $5,735 |
| Total | $3,693,821 |
Kramer received $1.4M in stock awards, accounting for 39% of the total pay in 2019.
Kramer also received $557.1K in non-equity incentive plan, $1M in option awards, $678K in salary and $5.7K in other compensation.
Rankings
In 2019, Robert G. Kramer's compensation ranked 3,271st out of 13,971 executives tracked by ExecPay. In other words, Kramer earned more than 76.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,271 out of 13,971 | 77th |
Division Manufacturing | 1,180 out of 5,695 | 79th |
Major group Chemicals And Allied Products | 401 out of 2,194 | 82nd |
Industry group Drugs | 330 out of 1,880 | 82nd |
Industry Pharmaceutical Preparations | 246 out of 1,392 | 82nd |
Source: SEC filing on April 9, 2020.
Kramer's colleagues
We found six more compensation records of executives who worked with Robert G. Kramer at Emergent BioSolutions in 2019.
2019
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2019
Fuad El-Hibri
Emergent BioSolutions
Chairman
2019
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
2019
Atul Saran
Emergent BioSolutions
General Counsel
2019
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2019
Daniel Abdun-Nabi
Emergent BioSolutions